- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 219-233 of
1,124 results
No. 22-9
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-9 (N.D.W.Va. May. 6, 2022)
|
|
Cite Document
No. 22-5
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-5 (N.D.W.Va. May. 6, 2022)
|
|
Cite Document
3001 Exhibit: Exhibit 3001
Document
IPR2024-00009, No. 3001 Exhibit - Exhibit 3001 (P.T.A.B. Feb. 13, 2024)
|
|
Cite Document
2023 Exhibit: EX2023 Notice of Service for Defendants’ Supplemental Invalidity Co...
Document
IPR2024-00009, No. 2023 Exhibit - EX2023 Notice of Service for Defendants’ Supplemental Invalidity Contentions, In re Ozempic Semaglutide Patent Litigation, No 22 MD 03038 CFC D Del Nov...
|
|
Cite Document
2020 Exhibit: EX2020 Novo Nordisk Production Letter, In re Ozempic Semaglutide ...
Document
IPR2024-00009, No. 2020 Exhibit - EX2020 Novo Nordisk Production Letter, In re Ozempic Semaglutide Patent Litigation, No 22 MD 03038 CFC D Del Oct 17, 2023 REDACTED (P.T.A.B. Jan. 26...
|
|
Cite Document
2001 Exhibit: EX2001 Excerpt of Defendants’ Initial Invalidity Contentions Regarding US Patent Nos 8,129,343 8,536,122 8,1...
Document
IPR2024-00009, No. 2001 Exhibit - EX2001 Excerpt of Defendants’ Initial Invalidity Contentions Regarding US Patent Nos 8,129,343 8,536,122 8,114,833 8,920,383 9,775,953 9,457,154 and 10,335,462, In
|
|
Cite Document
2018 Exhibit: EX2018 Excerpt of Defendants’ Supplemental Invalidity Contentions Regarding US Patent Nos 8,129,343 8,536,122 8,114,833 8...
Document
IPR2024-00009, No. 2018 Exhibit - EX2018 Excerpt of Defendants’ Supplemental Invalidity Contentions Regarding US Patent Nos 8,129,343 8,536,122 8,114,833 8,920,383 9,775,953 9,457,154 and 10,335,462
|
|
Cite Document
2012 Exhibit: EX2012 Waiver of Service of Summons for Dr Reddy’s Laboratories, ...
Document
IPR2024-00009, No. 2012 Exhibit - EX2012 Waiver of Service of Summons for Dr Reddy’s Laboratories, Inc, Novo Nordisk Inc v Dr Reddy’s Lab’ys Ltd, No 122 cv 00298 CFC, Dkt 6 D Del, Mar 4,...
|
|
Cite Document
2002 Exhibit: EX2002 Petition for Inter Partes Review, Mylan Pharms Inc v Novo No...
Document
IPR2024-00009, No. 2002 Exhibit - EX2002 Petition for Inter Partes Review, Mylan Pharms Inc v Novo Nordisk AS, IPR2023 00724, Pap1 Mar 16, 2023 (P.T.A.B. Jan. 26, 2024)
|
|
Cite Document
2022 Exhibit: EX2022 Notice of Service for Defendants’ Initial Invalidity Contention...
Document
IPR2024-00009, No. 2022 Exhibit - EX2022 Notice of Service for Defendants’ Initial Invalidity Contentions, In re Ozempic Semaglutide Patent Litigation, No 22 MD 03038 CFC D Del Oct 20, 2022...
|
|
Cite Document
2013 Exhibit: EX2013 Waiver of Service of Summons for Dr Reddy’s Laboratories L...
Document
IPR2024-00009, No. 2013 Exhibit - EX2013 Waiver of Service of Summons for Dr Reddy’s Laboratories Ltd, Novo Nordisk Inc v Dr Reddy’s Lab’ys Ltd, No 122 cv 00298 CFC, Dkt 7 D Del Mar 4, 2...
|
|
Cite Document
2019 Exhibit: EX2019 Novo Nordisk Production Letter, In re Ozempic Semaglutide ...
Document
IPR2024-00009, No. 2019 Exhibit - EX2019 Novo Nordisk Production Letter, In re Ozempic Semaglutide Patent Litigation, No 22 MD 03038 CFC D Del Oct 17, 2023 REDACTED (P.T.A.B. Jan. 26...
|
|
Cite Document
... EX2015 Excerpt of Novo Nordisk’s Initial Responses to Defendants’ Initial Invalidity Contentions Regarding US Patent Nos 8,129,343 8,536,122 8,1...
Document
IPR2024-00009, No. 2015 Exhibit - EX2015 Excerpt of Novo Nordisk’s Initial Responses to Defendants’ Initial Invalidity Contentions Regarding US Patent Nos 8,129,343 8,536,122 8,114,833 8...
|
|
Cite Document
2003 Exhibit: EX2003 Declaration of Sayem Osman
Document
IPR2024-00009, No. 2003 Exhibit - EX2003 Declaration of Sayem Osman (P.T.A.B. Jan. 26, 2024)
|
|
Cite Document
2005 Exhibit: EX2005 Nov 29, 2023 Email from E Goldschlager to Counsel, re IPR2...
Document
IPR2024-00009, No. 2005 Exhibit - EX2005 Nov 29, 2023 Email from E Goldschlager to Counsel, re IPR2023 00724 – Request for Conference Call (P.T.A.B. Jan. 26, 2024)
|
|
Cite Document
